Literature DB >> 21300463

Evaluation of microscopic disease in oral tongue cancer using whole-mount histopathologic techniques: implications for the management of head-and-neck cancers.

Sorcha Campbell1, Ian Poon, Dan Markel, Dan Vena, Kevin Higgins, Dan Enepekides, Simon Rapheal, John Wong, Ghassan Allo, Eric Morgen, Nader Khaoum, Ben Smith, Judith Balogh, Robert MacKenzie, Jean Davidson, Dan Wang, Martin Yaffe.   

Abstract

PURPOSE: To map the distribution of microscopic disease (MD) in head-and-neck cancer by analyzing digital images of whole-mounted serial sections of tongue cancer specimens. METHODS AND MATERIALS: Ten T1-3 oral tongue cancer specimens were evaluated. The specimens were sliced into 3-mm blocks from which one or more 4-μm slides were taken and digitized to create whole-mounted serial sections. Gross tumor and microscopic disease were digitally contoured on each slide. Lines perpendicular to the gross tumor volume (GTV) edge were created at 0.05-mm intervals and the distance between GTV and MD measured.
RESULTS: Of 88 slides assessed, 44 (50%) had evidence of MD. Of the 63,809 perpendicular lines drawn along the GTV edges, 2320 (3.6%) encountered microscopic disease along their path. The majority of MD abutted the GTV, and only 26.7% was noncontiguous with the GTV edge. The maximum distance from the border was 7.8 mm. Ninety-nine percent of all MD was within 4.75 mm and 95% was within 3.95 mm of the GTV.
CONCLUSION: In this study we were able to assess the distribution of MD more accurately than has been possible with routine pathologic techniques. The results indicate that when the GTV is correctly identified, there is very little MD to be found outside this volume. This has implications for the volume of tissue resected at surgery and the volume included in the clinical target volume in conformal radiotherapy planning. Crown
Copyright © 2012. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21300463     DOI: 10.1016/j.ijrobp.2010.09.038

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

1.  Recurrent oropharyngeal cancer after organ preserving treatment: pattern of failure and survival.

Authors:  M de Ridder; Z A R Gouw; J J Sonke; A Navran; B Jasperse; J Heukelom; M E T Tesselaar; W M C Klop; M W M van den Brekel; Abrahim Al-Mamgani
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-09       Impact factor: 2.503

2.  Dose accumulation to assess the validity of treatment plans with reduced margins in radiotherapy of head and neck cancer.

Authors:  Nicholas J Lowther; Steven H Marsh; Robert J W Louwe
Journal:  Phys Imaging Radiat Oncol       Date:  2020-06-10

Review 3.  The clinical target volume in lung, head-and-neck, and esophageal cancer: Lessons from pathological measurement and recurrence analysis.

Authors:  Rudi Apolle; Maximilian Rehm; Thomas Bortfeld; Michael Baumann; Esther G C Troost
Journal:  Clin Transl Radiat Oncol       Date:  2017-03-21

4.  Verification of HE-based CTV in laryngeal and hypopharyngeal cancer using pan-cytokeratin.

Authors:  Hans Ligtenberg; Stefan M Willems; Lilian N Ruiter; Elise Anne Jager; Chris H J Terhaard; Cornelis P J Raaijmakers; Marielle E P Philippens
Journal:  Clin Transl Radiat Oncol       Date:  2018-07-11

5.  Volumetric and dosimetric comparison of two delineation guidelines for the radiation treatment of laryngeal squamous cell carcinoma.

Authors:  C Bondue; S Racadot; A Coutte; P Dupuis; M C Biston; V Grégoire
Journal:  Clin Transl Radiat Oncol       Date:  2019-06-20

6.  Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy.

Authors:  Simon Keek; Sebastian Sanduleanu; Frederik Wesseling; Reinout de Roest; Michiel van den Brekel; Martijn van der Heijden; Conchita Vens; Calareso Giuseppina; Lisa Licitra; Kathrin Scheckenbach; Marije Vergeer; C René Leemans; Ruud H Brakenhoff; Irene Nauta; Stefano Cavalieri; Henry C Woodruff; Tito Poli; Ralph Leijenaar; Frank Hoebers; Philippe Lambin
Journal:  PLoS One       Date:  2020-05-22       Impact factor: 3.240

7.  Does 5 + 5 Equal Better Radiation Treatment Plans in Head and Neck Cancers?

Authors:  Mark T Corkum; Sylvia Mitchell; Varagur Venkatesan; Nancy Read; Andrew Warner; David A Palma
Journal:  Adv Radiat Oncol       Date:  2019-06-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.